Europe Life Sciences Weekly Signal #36: Buying Capability, Earning the Outcome
Week of 4–10 May 2026 Capability can be bought faster than it can be built. That was the clearest signal in European life sciences this week. Roche moved to acquire PathAI and bring more of the digital pathology workflow inside the diagnostics business. UCB spent up to $2.2 billion to buy into T-cell engagers for…
